🇺🇸 FDA
Patent

US 7267823

Ebola peptides and immunogenic compositions containing same

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 7267823 (Ebola peptides and immunogenic compositions containing same) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K38/00, A61K39/00